Search Orphan Drug Designations and Approvals
-
Generic Name: | Calcium acetate | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Trade Name: | Phos-Lo | ||||||||||||||||
Date Designated: | 12/22/1988 | ||||||||||||||||
Orphan Designation: | Treatment of hyperphosphatemia in end stage renal failure. | ||||||||||||||||
Orphan Designation Status: | Designated/Approved | ||||||||||||||||
Sponsor: |
Fresenius Medical Care North America 920 Winter Street Waltham, Massachusetts 02451 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
||||||||||||||||
Marketing approved: |
|||||||||||||||||
1 | Generic Name: | Calcium acetate |
---|---|---|
Trade Name: | Phos-Lo | |
Marketing Approval Date: | 12/10/1990 | |
Approved Labeled Indication: | ||
Exclusivity End Date: | 12/10/1997 | |
Exclusivity Protected Indication* : | ||
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-